Pacific Shuanglin Bio pharmacy Co Ltd (000403) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥70.28 Million ≈ $10.28 Million USD) by net assets (CN¥8.03 Billion ≈ $1.17 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000403 net asset quality index to measure how much of total assets are equity-financed.

Pacific Shuanglin Bio pharmacy Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Pacific Shuanglin Bio pharmacy Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000403 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Pacific Shuanglin Bio pharmacy Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pacific Shuanglin Bio pharmacy Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ingersoll Rand (India) Limited NSE:INGERRAND	0.195x
Perrigo Company PLC NYSE:PRGO	-0.045x
Zhejiang Fenglong Electric Co Ltd Class A SHE:002931	0.012x
Fujian Expressway Development Co Ltd SHG:600033	0.045x
Métropole Télévision S.A. PA:MMT	0.037x
Wondershare Technology Co Ltd Class A SHE:300624	0.032x
Great Wall Enterprise Co Ltd TW:1210	0.044x
Tamilnad Mercantile Bank Limited NSE:TMB	-0.323x

Annual Cash Flow Conversion Efficiency for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Pacific Shuanglin Bio pharmacy Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 000403 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.08 Billion ≈ $1.18 Billion	CN¥-215.99 Million ≈ $-31.61 Million	-0.027x	-165.76%
2024-12-31	CN¥7.92 Billion ≈ $1.16 Billion	CN¥321.79 Million ≈ $47.09 Million	0.041x	-55.58%
2023-12-31	CN¥7.42 Billion ≈ $1.09 Billion	CN¥679.01 Million ≈ $99.36 Million	0.091x	+19.74%
2022-12-31	CN¥6.86 Billion ≈ $1.00 Billion	CN¥524.22 Million ≈ $76.71 Million	0.076x	+18.43%
2021-12-31	CN¥6.33 Billion ≈ $925.95 Million	CN¥408.22 Million ≈ $59.74 Million	0.065x	-67.99%
2020-12-31	CN¥966.91 Million ≈ $141.49 Million	CN¥194.84 Million ≈ $28.51 Million	0.202x	-15.36%
2019-12-31	CN¥801.60 Million ≈ $117.30 Million	CN¥190.84 Million ≈ $27.93 Million	0.238x	+26.45%
2018-12-31	CN¥619.48 Million ≈ $90.65 Million	CN¥116.63 Million ≈ $17.07 Million	0.188x	+393.01%
2017-12-31	CN¥558.88 Million ≈ $81.78 Million	CN¥-35.91 Million ≈ $-5.26 Million	-0.064x	-156.24%
2016-12-31	CN¥546.91 Million ≈ $80.03 Million	CN¥62.49 Million ≈ $9.14 Million	0.114x	-14.61%
2015-12-31	CN¥525.49 Million ≈ $76.90 Million	CN¥70.31 Million ≈ $10.29 Million	0.134x	-20.34%
2014-12-31	CN¥458.65 Million ≈ $67.11 Million	CN¥77.04 Million ≈ $11.27 Million	0.168x	-35.09%
2013-12-31	CN¥351.68 Million ≈ $51.46 Million	CN¥91.01 Million ≈ $13.32 Million	0.259x	-39.60%
2012-12-31	CN¥287.68 Million ≈ $42.10 Million	CN¥123.24 Million ≈ $18.03 Million	0.428x	-6.92%
2011-12-31	CN¥282.74 Million ≈ $41.37 Million	CN¥130.14 Million ≈ $19.04 Million	0.460x	+1176.66%
2010-12-31	CN¥274.00 Million ≈ $40.09 Million	CN¥9.88 Million ≈ $1.45 Million	0.036x	-95.56%
2009-12-31	CN¥137.64 Million ≈ $20.14 Million	CN¥111.86 Million ≈ $16.37 Million	0.813x	+92.34%
2008-12-31	CN¥177.26 Million ≈ $25.94 Million	CN¥74.90 Million ≈ $10.96 Million	0.423x	-95.59%
2007-12-31	CN¥9.92 Million ≈ $1.45 Million	CN¥95.03 Million ≈ $13.91 Million	9.578x	+2397.05%
2006-12-31	CN¥-27.16 Million ≈ $-3.97 Million	CN¥-10.42 Million ≈ $-1.52 Million	0.384x	-12.05%
2005-12-31	CN¥112.49 Million ≈ $16.46 Million	CN¥49.06 Million ≈ $7.18 Million	0.436x	+299.35%
2004-12-31	CN¥602.14 Million ≈ $88.11 Million	CN¥-131.73 Million ≈ $-19.28 Million	-0.219x	-271.64%
2003-12-31	CN¥840.33 Million ≈ $122.97 Million	CN¥-49.47 Million ≈ $-7.24 Million	-0.059x	-128.81%
2002-12-31	CN¥779.03 Million ≈ $114.00 Million	CN¥159.18 Million ≈ $23.29 Million	0.204x	+26.30%
2001-12-31	CN¥687.82 Million ≈ $100.65 Million	CN¥111.28 Million ≈ $16.28 Million	0.162x	+254.33%
2000-12-31	CN¥599.28 Million ≈ $87.69 Million	CN¥27.36 Million ≈ $4.00 Million	0.046x	+195.34%
1999-12-31	CN¥481.83 Million ≈ $70.51 Million	CN¥-23.08 Million ≈ $-3.38 Million	-0.048x	-326.45%
1998-12-31	CN¥235.63 Million ≈ $34.48 Million	CN¥-2.65 Million ≈ $-387.22K	-0.011x	--

About Pacific Shuanglin Bio pharmacy Co Ltd

SHE:000403 China Biotechnology

Market Cap

$1.48 Billion

CN¥10.09 Billion CNY

Market Cap Rank

#7189 Global

#1515 in China

Share Price

CN¥10.62

Change (1 day)

+1.82%

52-Week Range

CN¥8.79 - CN¥18.89

All Time High

CN¥49.14